| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Axitinib | CTRPv2 | pan-cancer | AAC | -0.051 | 0.1 |
| mRNA | CCT036477 | CTRPv2 | pan-cancer | AAC | -0.05 | 0.1 |
| mRNA | SRT-1720 | CTRPv2 | pan-cancer | AAC | -0.055 | 0.1 |
| mRNA | compound 1B | CTRPv2 | pan-cancer | AAC | -0.057 | 0.1 |
| mRNA | Crizotinib | CTRPv2 | pan-cancer | AAC | -0.048 | 0.1 |
| mRNA | Rapamycin | CTRPv2 | pan-cancer | AAC | -0.05 | 0.1 |
| mRNA | SU11274 | CTRPv2 | pan-cancer | AAC | -0.052 | 0.1 |
| mRNA | WP1130 | CTRPv2 | pan-cancer | AAC | -0.052 | 0.1 |
| mRNA | OSI-930 | CTRPv2 | pan-cancer | AAC | 0.053 | 0.1 |
| mRNA | BRD1835 | CTRPv2 | pan-cancer | AAC | -0.055 | 0.1 |